Cargando…
Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach
BACKGROUND: Ebola viral disease is a severe and mostly fatal disease in humans caused by Ebola virus. This virus belongs to family Filoviridae and is a single-stranded negative-sense virus. There is no single treatment for this disease which puts forth the need to identify new therapy to control and...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757320/ https://www.ncbi.nlm.nih.gov/pubmed/29333037 http://dx.doi.org/10.4103/pr.pr_30_17 |
_version_ | 1783290836525514752 |
---|---|
author | Baikerikar, Shruti |
author_facet | Baikerikar, Shruti |
author_sort | Baikerikar, Shruti |
collection | PubMed |
description | BACKGROUND: Ebola viral disease is a severe and mostly fatal disease in humans caused by Ebola virus. This virus belongs to family Filoviridae and is a single-stranded negative-sense virus. There is no single treatment for this disease which puts forth the need to identify new therapy to control and treat this fatal condition. Curcumin, one of the bioactives of turmeric, has proven antiviral property. OBJECTIVE: The current study evaluates the inhibitory activity of curcumin, bisdemethoxycurcumin, demethoxycurcumin, and tetrahydrocurcumin against Zaire Ebola viral proteins (VPs). MATERIALS AND METHODS: Molecular simulation of the Ebola VPs followed by docking studies with ligands comprising curcumin and related compounds was performed. RESULTS: The highest binding activity for VP40 is −6.3 kcal/mol, VP35 is −8.3 kcal/mol, VP30 is −8.0 kcal/mol, VP24 is −7.7 kcal/mol, glycoprotein is −7.1 kcal/mol, and nucleoprotein is 6.8 kcal/mol. CONCLUSION: Bisdemethoxycurcumin shows better binding affinity than curcumin for most VPs. Metabolite tetrahydrocurcumin also shows binding affinity comparable to curcumin. These results indicate that curcumin, curcuminoids, and metabolite tetrahydrocurcumin can be potential lead compounds for developing a new therapy for Ebola viral disease. SUMMARY: Curcumin, bisdemethoxycurcumin, and demethoxycurcumin are active constituents of turmeric. Tetrahydrocurcumin is the major metabolite of curcumin formed in the body after consumption and absorption of curcuminoids. Curcuminoids have proven antiviral activity. Bisdemethoxycurcumin showed maximum inhibition of Ebola viral proteins (VPs) among the curcuminoids in the docking procedure with a docking score as high as −8.3 kcal/mol. Tetrahydrocurcumin showed inhibitory activity against Ebola VPs close to that of curcumin’s inhibitory action. [Image: see text] Abbreviations Used: EBOV: Ebola virus, GP: Glycoprotein, NP: Nucleoprotein, NPT: Isothermal-isobaric Ensemble, amount of substance (N), pressure (P) and temperature (T) conserved, NVE: Canonical ensemble, amount of substance (N), volume (V) and temperature (T) conserved, VP: Viral protein. |
format | Online Article Text |
id | pubmed-5757320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-57573202018-01-12 Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach Baikerikar, Shruti Pharmacognosy Res Original Article BACKGROUND: Ebola viral disease is a severe and mostly fatal disease in humans caused by Ebola virus. This virus belongs to family Filoviridae and is a single-stranded negative-sense virus. There is no single treatment for this disease which puts forth the need to identify new therapy to control and treat this fatal condition. Curcumin, one of the bioactives of turmeric, has proven antiviral property. OBJECTIVE: The current study evaluates the inhibitory activity of curcumin, bisdemethoxycurcumin, demethoxycurcumin, and tetrahydrocurcumin against Zaire Ebola viral proteins (VPs). MATERIALS AND METHODS: Molecular simulation of the Ebola VPs followed by docking studies with ligands comprising curcumin and related compounds was performed. RESULTS: The highest binding activity for VP40 is −6.3 kcal/mol, VP35 is −8.3 kcal/mol, VP30 is −8.0 kcal/mol, VP24 is −7.7 kcal/mol, glycoprotein is −7.1 kcal/mol, and nucleoprotein is 6.8 kcal/mol. CONCLUSION: Bisdemethoxycurcumin shows better binding affinity than curcumin for most VPs. Metabolite tetrahydrocurcumin also shows binding affinity comparable to curcumin. These results indicate that curcumin, curcuminoids, and metabolite tetrahydrocurcumin can be potential lead compounds for developing a new therapy for Ebola viral disease. SUMMARY: Curcumin, bisdemethoxycurcumin, and demethoxycurcumin are active constituents of turmeric. Tetrahydrocurcumin is the major metabolite of curcumin formed in the body after consumption and absorption of curcuminoids. Curcuminoids have proven antiviral activity. Bisdemethoxycurcumin showed maximum inhibition of Ebola viral proteins (VPs) among the curcuminoids in the docking procedure with a docking score as high as −8.3 kcal/mol. Tetrahydrocurcumin showed inhibitory activity against Ebola VPs close to that of curcumin’s inhibitory action. [Image: see text] Abbreviations Used: EBOV: Ebola virus, GP: Glycoprotein, NP: Nucleoprotein, NPT: Isothermal-isobaric Ensemble, amount of substance (N), pressure (P) and temperature (T) conserved, NVE: Canonical ensemble, amount of substance (N), volume (V) and temperature (T) conserved, VP: Viral protein. Medknow Publications & Media Pvt Ltd 2017-12 /pmc/articles/PMC5757320/ /pubmed/29333037 http://dx.doi.org/10.4103/pr.pr_30_17 Text en Copyright: © 2017 Pharmacognosy Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Baikerikar, Shruti Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach |
title | Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach |
title_full | Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach |
title_fullStr | Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach |
title_full_unstemmed | Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach |
title_short | Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach |
title_sort | curcumin and natural derivatives inhibit ebola viral proteins: an in silico approach |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757320/ https://www.ncbi.nlm.nih.gov/pubmed/29333037 http://dx.doi.org/10.4103/pr.pr_30_17 |
work_keys_str_mv | AT baikerikarshruti curcuminandnaturalderivativesinhibitebolaviralproteinsaninsilicoapproach |